KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Cash from Financing Activities (2016 - 2026)

National Health Investors filings provide 18 years of Cash from Financing Activities readings, the most recent being $55.8 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 60.1% to $55.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$58.3 million, a 135.95% decrease, with the full-year FY2025 number at $25.7 million, up 289.48% from a year prior.
  • Cash from Financing Activities hit $55.8 million in Q1 2026 for National Health Investors, down from $57.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $139.8 million in Q1 2025 to a low of -$244.9 million in Q2 2022.
  • Median Cash from Financing Activities over the past 5 years was -$36.2 million (2022), compared with a mean of -$29.6 million.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 571.7% in 2023 and later skyrocketed 489.08% in 2025.
  • National Health Investors' Cash from Financing Activities stood at -$7.4 million in 2022, then tumbled by 571.7% to -$49.4 million in 2023, then surged by 327.37% to $112.4 million in 2024, then plummeted by 49.01% to $57.3 million in 2025, then dropped by 2.66% to $55.8 million in 2026.
  • The last three reported values for Cash from Financing Activities were $55.8 million (Q1 2026), $57.3 million (Q4 2025), and -$41.9 million (Q3 2025) per Business Quant data.